Standverwaltung
Option auswählen

Multigon Industries, Inc.

525 Executive Boulevard, 10523 Elmsford, NY
USA
Telefon +1 914 3765200
Fax +1 914 3761111
stern_william@yahoo.com

Dieser Aussteller ist Hauptaussteller von

Hallenplan

MEDICA 2019 Hallenplan (Halle 9): Stand B46

Geländeplan

MEDICA 2019 Geländeplan: Halle 9

Unser Angebot

Produktkategorien

  • 01  Elektromedizin / Medizintechnik
  • 01.02  Bildgebende Verfahren
  • 01.02.04  Ultraschalldiagnostikgeräte

Unsere Produkte

Produktkategorie: Ultraschalldiagnostikgeräte

ROBOTOC2MD LUNCHBOX

The Nexgen Robtic TCD system, Duel Channel, Self Contained configuration, DICOM compatible, Captongraph compatible, Utilizes the Robotic fixation device. Designed for the Hospital using multiple applications. Structured reporting included.

Mehr Weniger

Produktkategorie: Ultraschalldiagnostikgeräte

Ultrasound System with Robotic Headband

Digital Transcranial Doppler (TCD) Ultrasound System with Robotic Headband for auto-tracking offers the best solution for Long-term monitoring. The ROBOTOC2MD locks on to the signal and maintains it despite patient or head movement.

Mehr Weniger

Über uns

Firmenporträt

Our Company History

In the 1970’s, UNIGON INDUSTRIES introduced the ANGIOSCAN, the first commercially available medical blood flow spectrum analyzer.  Previously, spectral analysis had been used as a method of evaluating sound frequency, permitting reproducible scientific classification and evaluation of sound.  This technology had many applications including speech analysis, underwater sound analysis, geophysics, and animal sound studies.

In the medical field, B-mode imaging was used in conjunction with Doppler to evaluate blood flow in arteries and veins.  This technique had several drawbacks.  The Doppler sound analysis was based on the operator’s hearing and mental evaluation of the sound, making the technique extremely operator dependent.  Because of this it was impossible to accurately determine the degree of stenosis.  The results of studies were not scientifically reproducible.  Also, no information was available about the direction of blood flow.

Dr. William Stern, one of the founders of UNIGON, worked with Dr. Robert Barnes and Dr. Stan Rittgers to develop the ANGIOSCAN.  The ANGIOSCAN allowed clinicians to evaluate and numerically quantify blood flow velocity in the body, and to determine direction of flow.  Spectral analysis heralded a revolution in non-invasive testing.

The ANGIOSCAN was used to develop many Doppler applications, including the first transcranial Doppler developed by Dr. Rune Aaslid.  MULTIGON also pioneered the use of Umbilical Doppler Velocimetry, a non-invasive blood flow test that has become a standard in prenatal care.  Today, spectral analysis is found on most ultrasound systems.

In 1983, UNIGON was acquired by ARTRA INC and later by GENERAL ELECTRIC CORP. UNIGON’s original team of scientists and engineers regrouped to form MULTIGON. Today, MULTIGON continues it’s tradition with the all-digital ROBOTOC2MD a NEXGEN TCD with a robotic headband, and a comprehensive suite of TCD protocols, measurements and reporting. Our commitment to “Excellence in Ultrasound” remains strong. Multigon TCD’s prove themselves every day at over 1000 installations worldwide.

MULTIGON is a U.S. owned company with representatives and distributors serving the medical community around the globe. All equipment is manufactured in Elmsford, New York. The NEUROVISION ROBOTOC2MD with ROBOTIC PROBES represents the culmination of years of experience, scientific research and interface with the medical community.

Mehr Weniger